Capturing the “Patient Voice” in Health Care

Published May 22, 2017
Presentation Explores Methods to Best Quantify Patient Input Boston, MA—May 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session at its 22nd Annual International Meeting that explored what methods researchers and health technology assessors should employ to best capture the patient voice in HEOR research. The issue panel held this afternoon in Boston, MA, USA, Voices and Echoes: What Methods Should We Be Using to Capture the Patient Voice [IP5], was moderated by Alaa Hamed, MD, MPH, MBA, Business Partner–Rare Disease, Health Economics and Outcomes Research, Sanofi Genzyme, Cambridge, MA, USA. Panelists included:
  • Kevin Marsh, PhD, Executive Director, Evidera Ltd, London, UK
  • Chad Gwaltney, PhD, Principal Consultant, Gwaltney Consulting, Westerly, RI, USA
  • John F. P. Bridges, PhD, Associate Professor, Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
While many health care stakeholders agree about the importance of involving patients in the process of health technology assessment, much debate still exists over how to best achieve this objective. For example, today there is no consensus as to what methodology should be used to capture the patient voice and in which circumstances these methods should be applied. The panel debated the pros and cons of different methodological approaches to incorporate and quantify patient input by reviewing three distinct approaches: 1) multiple criteria decision analysis (presented by Kevin Marsh, PhD), 2) patient-reported outcomes methods (presented by Chad Gwaltney, PhD), and 3) proposed stated preference methods (presented by John F. P. Bridges, PhD). The panel also briefly discussed other methods that have been put forward, such as analysis of social media data. Additional information on the ISPOR 22nd Annual International Meeting can be found here. Released presentations from the conference can be found here. Interested parties can follow conference news at ISPOR’s press site and on social media using the conference hashtag #ISPORBoston.

###

  ABOUT ISPOR The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Tackles Health Disparities with New Research Primer

Jan 22, 2025

ISPOR announced today the publication of a report from the ISPOR Health Equity Research Special Interest Group intended to establish key concepts for conducting health equity research that enables investigators to examine—and ultimately reduce—unfair social inequities in health.

Global Expert Panel Releases Good Practices Guidance for Developing or Updating Health Technology Assessment Guidelines

Jan 14, 2025

ISPOR announced today the publication of a tripartite task force report outlining good practices for developing or updating health technology assessment (HTA) guidelines.

Rethinking Value Assessment for Orphan Drugs

Dec 18, 2024

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that document challenges in rare disease evidence and economic evaluation and policy as well as ways in which the environment is evolving to address them.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×